CRB-378

N/A

Report date: 2025/01/26 18:02:43
NME

Base Information

Drug NameCRB-378
Drug Alias Namecannabinoid CB2 agonist (Corbus Pharmaceuticals)CRB-378
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor agonists
TargetsCannabinoid CB2 receptor
Therapy Area/IndicationsSolid tumoursTriple Negative Breast NeoplasmsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCorbus Pharmaceuticals Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesCorbus Pharmaceuticals Holdings Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursTriple Negative Breast NeoplasmsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A